Grace Halsey

Finerenone, in patients with mild-to-moderate renal disease and T2D, reduced CV event risk by 13% and risk for a composite renal event by 23%, study authors reported at ESC 2021.

Why wouldn't a person with severe obesity want to talk about bariatric surgery? Why wouldn't the patient's physician want to do it? The reasons for hesitation are many.

Empagliflozin in patients with HFpEF reduced by 21% the risk of cardiovascular death or heart failure hospitalization across all prespecified subgroups, including those with/without diabetes.

IAC president Kelly Moore, MD, MPH, has a long history of fighting flu and promoting vaccination. She talks about the influenza/COVID season to come and using the best tools we have.

The ESC Congress 2021, Aug 27-30, 2021, is here. For primary care, we highlight the "Hot Lines" clinical trial presentations where new data from novel trials will premier.

Citing data that show the incidence of type 2 diabetes increases at age 35 years, the Task Force now recommends the younger age to initiate screening vs the current age of 40 years.

Low rates of routine adult vaccination, reduced further during the 2020-21 pandemic months, threaten a surge in these conditions as the US reopens, says the National Adult and Influenza Immunization Summit.

With the post-LER PAD indication, rivaroxaban becomes the only anticoagulant in 2 decades to demonstrate safety and efficacy in the high-risk population.

Talking to the COVID-19 vaccine-hesitant folks in your circle can be difficult. These 8 slides offer some new and some tried and true tips on how to approach the topic

The novel prandial insulin formulation from Eli Lilly is now approved for administration via continuous subcutaneous insulin infusion with an insulin pump.

COVID-19 patients after just 5 days or less in the hospital report new or worsened symptoms, impaired daily function, and significant financial loss.

The new indication for empagliflozin is to reduce risk of CV death and hospitalization for heart failure in patients with HFrEF,

Delta variant rising and vaccine immunity possibly on the wane are 2 reasons cited by state governors and city mayors for requiring full vaccination of health care personnel.

The American College of Physicians urges clinicians to make sure adult patients, especially the most vulnerable, are protected against preventable diseases as COVID spreads and flu is imminent.

Recommendation for a COVID-19 booster for vaccinated Americans could come by Wednesday; some experts say data are too sparse to support the move.

Delaying or forfeiting care for HF significantly increased future health care costs, a finding at odds, say study authors, with the inability to afford regular treatment.

COVID-19 vaccination mandates are not popular with parents of school-aged children, but masks for unvaccinated students and teachers are. More on a new KFF survey.

Click through a short summary of the provisions of the Dr Lorna Breen Health Care Provider Protection Act.

The first-of-its-kind legislation would authorize $35 million for programs aimed at practitioner mental health education and campaigns to support seeking help.

Update: The FDA authorized a 3rd COVID-19 vaccine dose for the immunocompromised to combat emergence of more pathogenic SARS-CoV-2 strains.

Your COVID-19-vaccinated patients and the ones "on the fence" share a fear, but of different unknowns. Reduce the threat for the fence sitters, says Afton Kapuscincki, PhD.

The COVID-19 vaccine hesitancy echoed to this PCP from his multiethnic community is rooted in confusion. He talks about creating clarity, here.

Older adults who report being "highly lonely" are up to 2.5 times more likely to use opioid analgesics, sedatives, and anxiolytics.

COVID-19 vaccine information that is culturally sensitive, clear, and concise may help reduce patient hesitation, but the PCP can shift a “maybe” to “yes.”

Patients with overweight and obesity rarely received guidance on weight management after hospitalization for a coronary event, authors report.

Patients unvaccinated against COVID-19 don't need blame; they may need more of your time, though, says this primary care physician.

As FHS continues, advanced technology leads to discovery of genetic CVD risk; imaging studies refine risk assessment; gamification enters FHS research; and a 2019 grant ensures the future.

Findings from the Framingham Heart Study since its 1948 beginning have led to identification of and treatment for dozens of risk factors for cardiovascular disease. Which ones?

Results of a new systematic review and meta-analysis by researchers at Penn State College of Medicine underscore needs for patient education and additional research on prevention.

Data from the CDC on the Delta variant and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.